Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amarin Corp Plc\Uk (AMRN) Gains from Sales and Divestitures (2016 - 2025)

Amarin Corp Plc\Uk (AMRN) has disclosed Gains from Sales and Divestitures for 12 consecutive years, with $8.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 121.78% to $8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 million, a 121.78% increase, with the full-year FY2025 number at $8.5 million, up 121.78% from a year prior.
  • Gains from Sales and Divestitures was $8.5 million for Q4 2025 at Amarin Corp Plc\Uk, up from $3.9 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $8.5 million in Q4 2025 to a low of $1.9 million in Q4 2022.
  • A 5-year average of $4.5 million and a median of $4.1 million in 2021 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: crashed 52.18% in 2022, then skyrocketed 121.78% in 2025.
  • Amarin Corp Plc\Uk's Gains from Sales and Divestitures stood at $4.1 million in 2021, then plummeted by 52.18% to $1.9 million in 2022, then skyrocketed by 119.02% to $4.2 million in 2023, then dropped by 9.34% to $3.9 million in 2024, then skyrocketed by 121.78% to $8.5 million in 2025.
  • Per Business Quant, the three most recent readings for AMRN's Gains from Sales and Divestitures are $8.5 million (Q4 2025), $3.9 million (Q4 2024), and $4.2 million (Q4 2023).